1.03
Schlusskurs vom Vortag:
$0.9872
Offen:
$0.99
24-Stunden-Volumen:
645.69K
Relative Volume:
0.67
Marktkapitalisierung:
$133.78M
Einnahmen:
$108.81M
Nettoeinkommen (Verlust:
$-186.70M
KGV:
-1.2233
EPS:
-0.842
Netto-Cashflow:
$-16.83M
1W Leistung:
-1.98%
1M Leistung:
-18.19%
6M Leistung:
-44.14%
1J Leistung:
-44.14%
Organigram Holdings Inc Stock (OGI) Company Profile
Vergleichen Sie OGI mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
OGI
Organigram Holdings Inc
|
1.03 | 133.78M | 108.81M | -186.70M | -16.83M | -0.842 |
![]()
ZTS
Zoetis Inc
|
161.19 | 71.40B | 9.26B | 2.49B | 2.30B | 5.47 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
15.01 | 47.36B | 30.25B | 1.37B | 5.08B | 0.4257 |
![]()
HLN
Haleon Plc Adr
|
10.14 | 46.03B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.33 | 18.86B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
ITCI
Intra Cellular Therapies Inc
|
131.26 | 13.96B | 612.78M | -86.37M | -62.91M | -0.87 |
Organigram Holdings Inc Stock (OGI) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-07-17 | Fortgesetzt | Canaccord Genuity | Speculative Buy |
2024-04-15 | Hochstufung | Alliance Global Partners | Neutral → Buy |
2023-01-13 | Hochstufung | Stifel | Hold → Buy |
2022-01-12 | Hochstufung | Canaccord Genuity | Hold → Speculative Buy |
2021-05-11 | Hochstufung | CIBC | Sector Underperform → Neutral |
2021-04-14 | Herabstufung | CIBC | Neutral → Sector Underperform |
2021-04-08 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
2021-03-10 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
2021-01-13 | Herabstufung | Alliance Global Partners | Buy → Neutral |
2021-01-13 | Herabstufung | Canaccord Genuity | Speculative Buy → Hold |
2020-07-07 | Eingeleitet | Alliance Global Partners | Buy |
2020-01-15 | Hochstufung | Raymond James | Mkt Perform → Outperform |
2020-01-13 | Eingeleitet | BofA/Merrill | Underperform |
2020-01-09 | Herabstufung | Raymond James | Outperform → Mkt Perform |
2019-11-12 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
2019-11-05 | Eingeleitet | Cantor Fitzgerald | Overweight |
2019-10-11 | Hochstufung | Jefferies | Hold → Buy |
Alle ansehen
Organigram Holdings Inc Aktie (OGI) Neueste Nachrichten
OrganiGram Holdings, Inc. to Host Earnings Call - ACCESS Newswire
Cannabis producer Organigram closes final tranche of CA$124.6M funding - Marijuana Business Daily
British American Tobacco buying at OrganiGram Holdings (OGI) - The Globe and Mail
Organigram Gets Final Investment From Tobacco Giant, Kanabo Sees Double Digit Revenue Increase, & More From Curity Pharma - Business of Cannabis -
Big Tobacco's Latest $86.8 Million Cannabis Investment Signals Growing Industry Influence - Benzinga India
Organigram Closes Third Tranche of Announced BAT Investment - mg Magazine
Organigram Holdings Announces Upcoming Shareholder Meeting By Investing.com - Investing.com Canada
Organigram Holdings Inc. - MENAFN.COM
Organigram Holdings Announces Upcoming Shareholder Meeting - Investing.com India
Organigram closes on final round of funding from British American Tobacco - StratCann
Organigram Completes Strategic Investment to Boost International Growth - TipRanks
Another C$41.5 Million Invested in Organigram - New Cannabis Ventures
BAT Now Owns 30% of Organigram After Final C$28.96M InvestmentWhat's Next for Jupiter Pool? - StockTitan
Organigram (TSE:OGI) Hits New 12-Month LowHere's Why - MarketBeat
Why Are Anheuser-Busch (BUD) Shares Soaring Today - The Globe and Mail
Corporate Stock News: February 26th, 2025 - The Globe and Mail
Organigram Reports In-Line Q1 Results As Cannabis Sector Tanks (NASDAQ:OGI) - Seeking Alpha
Organigram Is A Small-Cap Bargain - Seeking Alpha
OrganiGram Holdings: Top 10 Undervalued Drug Manufacturers Industry Stocks (OGI) - The Globe and Mail
Alliance Global Partners Comments on Organigram Q3 Earnings - MarketBeat
Organigram Holdings Inc. (OGI): A Bull Case Theory - Insider Monkey
Q3 EPS Estimates for Organigram Reduced by Atb Cap Markets - MarketBeat
Earnings call transcript: OrganiGram Q3 2024 shows revenue boost - MSN
Atb Cap Markets Forecasts Organigram FY2027 Earnings - MarketBeat
Organigram (TSE:OGI) Stock Price Down 16%Should You Sell? - MarketBeat
Organigram (TSE:OGI) Sets New 12-Month LowWhat's Next? - MarketBeat
Q3 EPS Estimates for Organigram Increased by Analyst - MarketBeat
Q3 EPS Estimates for Organigram Lowered by Atb Cap Markets - Defense World
Organigram (NASDAQ:OGI) Posts Quarterly Earnings Results, Misses Expectations By $0.02 EPS - MarketBeat
Organigram (NASDAQ:OGI) Releases Earnings Results, Misses Expectations By $0.02 EPS - MarketBeat
Organigram pins German growth on facility upgrades - Green Market Report
Organigram expands market share and targets 13,000 kg annual capacity boost with new initiatives - MSN
Analysts Offer Predictions for Organigram FY2027 Earnings - Defense World
OrganiGram Holdings Earnings Call Reveals Growth and Challenges - TipRanks
OrganiGram Holdings Inc. (NASDAQ:OGI) Q1 2025 Earnings Call Transcript - Insider Monkey
Organigram has price target chopped at Haywood - Cantech Letter
Organigram Reports First Quarter Fiscal 2025 Results - mg Magazine
OrganiGram Holdings Inc (OGI) Q1 2025 Earnings Call Highlights: - GuruFocus.com
OrganiGram Holdings Inc (OGI) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... - Yahoo Finance
OrganiGram Holdings Inc (OGI) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... By GuruFocus - Investing.com Canada
OrganiGram: Fiscal Q1 Earnings Snapshot - mySA
OrganiGram’s Financial Growth and Strategic Expansion - TipRanks
Organigram (OGI) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Earnings call transcript: OrganiGram Q3 2024 shows revenue boost By Investing.com - Investing.com Canada
Finanzdaten der Organigram Holdings Inc-Aktie (OGI)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):